• Profile
Close

Vimentin overexpression as a novel poor prognostic biomarker in eyelid sebaceous gland carcinoma

British Journal of Ophthalmology Apr 05, 2019

Bhardwaj M, et al. - A sum of 66 individuals with sebaceous gland carcinoma (SGC) were explored to estimate the role of Vimentin in SGC along with its association with epithelial-mesenchymal transition (EMT) markers E-cadherin, ZEB2, and Slug. Vimentin overexpression was revealed with immunohistochemistry (IHC) in 56% cases. A significant relationship was noted between the overexpression and lymph node metastasis as well as pagetoid spread. Poor disease-free survival was recorded among subjects with high Vimentin expression. They noticed high Vimentin expression and advanced tumor stage, independent adverse prognostic factors in the univariate Cox regression model. They overall implied a significant inverse correlation between Vimentin expression and E-cadherin as well as a direct association with ZEB2 expression.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay